At a glance
ClinicalIndex Comparison RecordN/ACompleted· 38 enrolled
Drug / intervention
Acute Resistance Exercisebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Muscle-derived Extracellular Vesicles and Their Interactions With Adipocytes in Human Metabolic Dysfunction
In Brief
A clinical study evaluating Acute Resistance Exercise for Metabolism. Completed, enrolled 38 participants across 1 site.
Detailed Summary
The primary objective of this study is to quantify miR-1 release from muscle in extra-cellular vesicles following an acute resistance exercise bout and potential delivery to subcutaneous adipose tissue in young healthy and obese adults.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMetabolism
CountriesUnited States
Timeline
N/ACompletedFinished
20192020202120222023202420252026
Enrollment StartMar 2019
First PostedAug 2020
Primary CompletionNov 2022
TodayJul 2026
First PostedAug 5, 2020
Enrollment StartMar 14, 2019
Primary CompletionNov 30, 2022
TodayJul 2, 2026
Enrollment to primary: 3.7 yearsPosted 5.9 years ago
Interventions
Acute Resistance Exercisebehavioral
Participants will perform three sets of eight repetitions, with a 90-120 second rest between sets, with a fourth set performed to failure. All resistance exercise will be performed on pneumatic resistance devices (Keiser Sports Health Equipment, Fresno, CA).